Bromocriptine mesylate
Tocris Bioscience, part of Bio-Techne | Catalog # 0427
D2-like agonist (D2>D3>D4)
Key Product Details
Description
D2-like agonist (D2>D3>D4)
Product Description
Bromocriptine mesylate is a selective D3 and D2 dopamine receptor agonist (Ki values are ~ 5 nM and ~ 8 nM respectively). Activates both isoforms of D2 receptor (EC50 values are 0.10-0.12 nM and 4.4 nM for D2L and D2S receptors, respectively. Bromocriptine shows anti-Aβ effects that are increased in combination with Cromolyn (Cat. No. 6424) and Topiramate (Cat. No. 3620). Also lowers glucose and increases insulin sensitivity in vivo.Product Specifications
Molecular Weight
750.70
Formula
C32H40BrN5O5.CH3SO3H
Storage
Store at RT
Purity
≥98% (HPLC)
Chemical Name
(5'a)-2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione mesylate
CAS Number
22260-51-1
PubChem ID
31100
InChI Key
NOJMTMIRQRDZMT-GSPXQYRGSA-N
SMILES
[H][C@]4([C@@](N[C@]([C@H](C)C)5C(N([C@@]([H])(CC(C)C)C(N(CCC7)[C@@]76[H])=O)[C@@]6(O)O5)=O)=O)CN([C@](C3=C4)([H])CC1=C(Br)NC2=C1C3=CC=C2)C.CS(=O)(O)=O
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 75.07 | 100 |
Preparing Stock Solutions
for Bromocriptine mesylate
The following data is based on the product molecular weight 750.70
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.33 mL | 6.66 mL | 13.32 mL |
| 5 mM | 0.27 mL | 1.33 mL | 2.66 mL |
| 10 mM | 0.13 mL | 0.67 mL | 1.33 mL |
| 50 mM | 0.03 mL | 0.13 mL | 0.27 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Tavares Dopamine D2 receptor agonist, bromocriptine, remodels adipose tissue dopaminergic signalling and upregulates catabolic pathways, improving metabolic profile in type 2 diabetes. Mol.Metab. 2021 PMID: 33933677
- Kondo iPSC-based compound screening and in vitro trials identify a synergistic anti-amyloid β combination for Alzheimer's disease. Cell Rep. 2017 PMID: 29166618
- Traub The effects of chronic bromocri. treatment on behaviour and DA receptor binding in the rat striatum. Eur.J.Pharmacol. 1985 PMID: 3936723
- Seeman and Van Tol DA receptor pharmacology. TiPS 1994 PMID: 7940991
- Lieberman and Goldstein Bromocriptine in Parkinson disease. Pharmacol.Rev. 1985 PMID: 3901046
- Aubner Bromocriptine produces decreases in cocaine self-administration in the rat. Neuropsychopharmacology 1990 PMID: 2317262
Product Specific Notices for Bromocriptine mesylate
For research use only
Loading...
Loading...